Kate is a corporate lawyer specialising in equity capital markets, mergers and acquisitions (private and public) and venture capital.

She has extensive experience in ECM transactions including IPOs, rights issues, placements and share purchase plans. She also specialises in public and private M&A transactions including takeover bids, schemes of arrangement and private treaty transactions.

Kate acts for ASX-listed companies in relation to their corporate transactions and has experience across a range of industries, with a focus on the health and technology and mining sectors. She also acts for private equity and venture capital firms in relation to their Australian investments. She has previously worked for major Australian banks in their in-house M&A legal teams.

Work highlights

Novo Resources Corp. (ASX: NVO, TSX: NVO, OTCQX: NSRPF)

IPO and dual listing of its CDIs on the ASX in 2023.

CurveBeam AI Limited (ASX:CVB)

IPO and listing on the ASX in 2023 and 2024 entitlement offer.

Bionomics Limited (NASDAQ:BNOX, OTCQB:BNOEF)

2021 Nasdaq IPO and 2022 US capital raise, 2023 At-the-market (ATM) offering on Nasdaq and 2024 Private Investment in Public Equity (PIPE).

Insight Partners

A$223 million investment in software start-up Octopus Deploy and A$14m investment in software start-up Devicie.

Clean Energy Finance Corporation

Participation in the Series B, C and D capital raisings in Sunman Energy and its investment in clean energy start-up, H2Lab.

CurveBeam AI Limited

Pre-IPO funding rounds.

Member of the JWS Team who was named Technology, Media and Telecom M&A Legal Adviser of the Year.

Mergermarket M&A Awards Australia (2023)

Member of the JWS Team who was nominated for the Transaction Team of the Year.

Australian Law Awards (2024)
1/2